Newbridge Financial Services Group Inc. Invests $30,000 in DaVita Inc. (NYSE:DVA)

Newbridge Financial Services Group Inc. acquired a new position in shares of DaVita Inc. (NYSE:DVA) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 285 shares of the company’s stock, valued at approximately $30,000.

Other large investors have also modified their holdings of the company. Principal Securities Inc. acquired a new stake in shares of DaVita in the fourth quarter worth $37,000. Hanseatic Management Services Inc. acquired a new stake in shares of DaVita in the third quarter worth $36,000. GAMMA Investing LLC acquired a new stake in shares of DaVita in the fourth quarter worth $60,000. Quest Partners LLC acquired a new stake in shares of DaVita in the fourth quarter worth $74,000. Finally, Federated Hermes Inc. boosted its position in shares of DaVita by 1,284.4% in the third quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after buying an additional 1,156 shares during the period. 90.12% of the stock is owned by institutional investors.

Insider Buying and Selling at DaVita

In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $138.81, for a total transaction of $698,214.30. Following the transaction, the director now directly owns 10,954 shares in the company, valued at $1,520,524.74. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.00% of the company’s stock.

DaVita Price Performance

Shares of NYSE:DVA opened at $142.18 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 1.37 and a debt-to-equity ratio of 7.95. DaVita Inc. has a 1 year low of $71.51 and a 1 year high of $147.93. The business has a fifty day simple moving average of $137.60 and a 200 day simple moving average of $124.63. The firm has a market cap of $12.47 billion, a price-to-earnings ratio of 16.16, a P/E/G ratio of 1.08 and a beta of 0.96.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The business had revenue of $3.07 billion during the quarter, compared to analyst estimates of $3.03 billion. During the same period last year, the company earned $1.58 earnings per share. DaVita’s quarterly revenue was up 6.9% compared to the same quarter last year. As a group, sell-side analysts predict that DaVita Inc. will post 9.62 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DVA has been the subject of several recent analyst reports. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. Barclays raised their target price on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Monday, May 6th. Finally, Truist Financial increased their price objective on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, May 15th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $144.67.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.